Aqua Regenerative Therapies, operating under the brand AQUA Biomaterials, is a biotechnology company focused on developing animal-free products and biomaterials. Their offerings include technical advice, product prototyping, and process development services. Key products feature antibody conjugates, natural and synthetic polymers, cell culture enhancements, custom hydrogel synthesis for stem cells, and cancer immunotherapy. Their proprietary nanoScyl® technology stabilizes bioactive molecules and has applications in brain tissue regeneration and enzyme lifetime enhancement.

AQUA Biomaterials has made significant strides in biotechnology, particularly with their nanoScyl® nanogel, which evolved from heparin nanoparticles developed at UCLA and featured in Nature Materials. This innovative material has demonstrated capabilities in regrowing brain tissue and enhancing biosensor enzyme lifetimes. The company's impact is marked by its commitment to animal-free solutions and advanced biomaterials, positioning them as a leader in the biotech industry.